News
CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates Entered into ...
TipRanks on MSN3h
CureVac reports Q2 revenue EUR 1.2M vs. EUR 14.4M last year
By entering into a definitive purchase agreement with BioNTech, we intend to unite two highly complementary German companies that are well ...
TipRanks on MSN3h
CureVac sees cash runway into 2028
Cash and cash equivalents amounted to EUR 392.7 million at the end of June 2025, decreasing from EUR 481.7 million at the end of 2024. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback